中文名 | AZD9291中间体1 |
---|---|
英文名 | N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine |
中文别名 | 奥斯替尼中间体3 |
英文别名 |
Mutated EGFR-IN-1
AZD9291 intermediate 3 1,2,4-Benzenetriamine, N-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-N-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- N-[2-(Dimethylamino)ethyl]-5-methoxy-N-methyl-N-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N 1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine |
描述 | Mutated EGFR-IN-1是突变型EGFR(L858R EGFR,Exonl9缺失活化突变和T790M抗性突变)抑制剂的中间体。 |
---|---|
相关类别 | |
靶点 |
EGFRL858R EGFRExon 19 deletion/T790M EGFRT790M |
参考文献 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 676.5±65.0 °C at 760 mmHg |
分子式 | C25H31N7O |
分子量 | 445.560 |
闪点 | 363.0±34.3 °C |
精确质量 | 445.259003 |
PSA | 84.47000 |
LogP | 2.17 |
蒸汽压 | 0.0±2.1 mmHg at 25°C |
折射率 | 1.635 |
储存条件 | 2-8℃ |